QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

23,346 signal articles · 381 in last 24h · 111,421 total before filter · latest 19m ago
381last 24h
2263last 7d
397● bullish (7d)
214● bearish (7d)
203publishers
AllMacro280Earnings1332M&A95Regulatory22Product16Analyst20
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?
StockStory61d agoneutral
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 20%. Its stock price has climbed to $100.39, representing a healthy 26.4% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

How To Earn $500 A Month From Jabil Stock Ahead Of Q3 Earnings
Benzinga61d agoneutral
How To Earn $500 A Month From Jabil Stock Ahead Of Q3 Earnings

Jabil Inc.will release earnings for its third quarter before the opening bell on Wednesday, June 17. Analysts expect the Florida-based manufacturer to report quarterly earnings of $3.10 per share. That’s up from $2.55 per share in the year-ago period. The...

Adobe Q2 Earnings Call Highlights
MarketBeat61d agoneutral
Adobe Q2 Earnings Call Highlights

Adobe (NASDAQ:ADBE) reported record fiscal second-quarter revenue and raised its full-year revenue outlook, while executives outlined a strategic shift toward more aggressive freemium user acquisition across Acrobat, Express and Firefly that is expected to weigh on second-half annual recurring reven

Cal-Maine (CALM): Buy, Sell, or Hold Post Q1 Earnings?
StockStory61d agoneutral
Cal-Maine (CALM): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, Cal-Maine’s stock price fell to $79.32. Shareholders have lost 9.4% of their capital, which is disappointing considering the S&P 500 has climbed by 6.9%. This might have investors contemplating their next move.

Vera Bradley Q1 Earnings Call Highlights
MarketBeat62d agoneutral
Vera Bradley Q1 Earnings Call Highlights

Vera Bradley (NASDAQ:VRA) reported a return to year-over-year revenue growth in the first quarter of fiscal 2027, with management pointing to improving product traction, tighter inventory control and lower expenses as signs that its turnaround plan is gaining momentum. Chairman and Chief Executive

Oracle Stock Slides on Mixed Earnings. Software Is an Issue.
Barrons.com62d agoneutral
Oracle Stock Slides on Mixed Earnings. Software Is an Issue.

Oracle shares fell in the Thursday premarket after the company reported mixed earnings results for its fiscal fourth quarter after the Wednesday bell. Oracle also said that its capital expenditures for the current fiscal year would be around $70 billion, plus another $20 billion to $25 billion paid directly by customers. In its just ended fiscal 2026 year, Oracle’s capex was $56 billion, up from $21 billion in fiscal 2025.

📈 Earnings Snippet: Oracle Spending
The Wall Street Journal62d agoneutral
📈 Earnings Snippet: Oracle Spending

Oracle expects a net cash outlay for capital expenditures of around $70 billion for fiscal 2027, Chief Financial Officer Hillary Maxson said Wednesday. The reported amount will be higher by about $20 billion to $25 billion due to prepayment and customer impacts.